© 2024 Replicate Bioscience | All rights reserved.
A segment of yellow, single-stranded RNA arcs across the right side of the page. Behind it is a blue-to-teal background overlaid with rows of simple human silhouettes. A bright white light trail animates following the arch of the RNA.
A segment of yellow, single-stranded RNA arcs across the right side of the page. Behind it is a blue-to-teal background overlaid with rows of simple human silhouettes. A bright white light trail animates following the arch of the RNA.

The Power of RNA Amplified

Impact measured in billions.

YOUR CELLs’ vERY OWN COPY MACHINERY

Our platform leverages next-generation self-replicating RNA (srRNA) vectors. Once inside cells, the genetic code of our srRNA drives repeated production of natural RNA, resulting in outsized protein expression and durable therapeutic effect.

OUR SCIENCe
A strand of srRNA floats upwards to the right. Behind it, copied mRNA segments are visible.
A strand of srRNA floats upwards to the right. Behind it, copied mRNA segments are visible.

ENABLING BROAd APPLICATIONs FOR RNA TREATMENTs

Replicate is advancing a robust pipeline of srRNA treatments spanning several therapeutic areas, including infectious disease, oncology, and autoimmune disorders. Improved performance over linear mRNA lets us help even more patients.

PIPELINe
A simple blue line-drawing pattern of human silhouettes arranged in three rows.
A simple blue line-drawing pattern of human silhouettes arranged in three rows.
A gradient blue background with a white, curved, light trail.
A gradient blue background with a white, curved, light trail.

News & Publications

03.01.24 Press Releases
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
Read more
02.14.24 News articles
Replicate’s srRNA rabies vaccine effective in Phase 1
Read more
02.14.24 News articles
Self-replicating RNA rabies vaccine clears early test, boosting Replicate’s plans for platform
Read more
VIEW ALL NEWs